ABIOSA PHARMA AS: årsregnskap 2022 vs 2021
Another loss-making year
approved 2023-06-30; registry 2023-08-15; journal 2023 708257
Summary
What changed
Comparing Årsregnskap 2022 with 2021 for ABIOSA PHARMA AS. Revenue 0 NOK → 0 NOK (0.0%). Net result -300 NOK → -300 NOK. Equity -8 884 NOK → -9 184 NOK.
Also worth watching: operating result unchanged; thin equity buffer. All figures are taken from the published annual accounts for ABIOSA PHARMA AS.
At a glance
Scorecard
Revenue
0 NOK
0 NOK
0.0%
Operating result
-300 NOK
-300 NOK
0.0%
Net result
-300 NOK
-300 NOK
0.0%
Equity
-8 884 NOK
-9 184 NOK
-3.4%
Cash
7 479 NOK
7 179 NOK
-4.0%
Total assets
7 479 NOK
7 179 NOK
-4.0%
Things to notice
-
·
Operating result unchanged
Operating result -300 NOK → -300 NOK. Calculated
-
·
Thin equity buffer
Equity ratio is -127.9% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation